These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9650617)

  • 1. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy.
    Freytag SO; Rogulski KR; Paielli DL; Gilbert JD; Kim JH
    Hum Gene Ther; 1998 Jun; 9(9):1323-33. PubMed ID: 9650617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells.
    Wu DH; Liu L; Chen LH
    World J Gastroenterol; 2005 May; 11(20):3051-5. PubMed ID: 15918188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.
    Hagen S; Baumann T; Wagner HJ; Morath V; Kaufmann B; Fischer A; Bergmann S; Schindler P; Arndt KM; Müller KM
    Sci Rep; 2014 Jan; 4():3759. PubMed ID: 24457557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health.
    Thoidingjam S; Sriramulu S; Freytag S; Brown SL; Kim JH; Chetty IJ; Siddiqui F; Movsas B; Nyati S
    Transl Med Commun; 2023; 8(1):11. PubMed ID: 37065938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer.
    Yang K; Feng S; Luo Z
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter.
    Wang G; Liu Y; Liu S; Lin Y; Hu C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements.
    Yun CO; Hong J; Yoon AR
    Front Immunol; 2022; 13():953410. PubMed ID: 36091031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G.
    Tong Y; Kikuhara S; Onodera T; Chen L; Myat AB; Imamichi S; Sasaki Y; Murakami Y; Nozaki T; Fujimori H; Masutani M
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric Cancer and Viruses: A Fine Line between Friend or Foe.
    Firoz A; Ali HM; Rehman S; Rather IA
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses.
    Farrera-Sal M; Fillat C; Alemany R
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy.
    Kanada M; Kim BD; Hardy JW; Ronald JA; Bachmann MH; Bernard MP; Perez GI; Zarea AA; Ge TJ; Withrow A; Ibrahim SA; Toomajian V; Gambhir SS; Paulmurugan R; Contag CH
    Mol Cancer Ther; 2019 Dec; 18(12):2331-2342. PubMed ID: 31451563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.
    Yokoda R; Nagalo BM; Vernon B; Oklu R; Albadawi H; DeLeon TT; Zhou Y; Egan JB; Duda DG; Borad MJ
    Oncolytic Virother; 2017; 6():39-49. PubMed ID: 29184854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.
    Huang JL; LaRocca CJ; Yamamoto M
    Biomedicines; 2016 Sep; 4(3):. PubMed ID: 28536390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell carriers for oncolytic viruses: current challenges and future directions.
    Roy DG; Bell JC
    Oncolytic Virother; 2013; 2():47-56. PubMed ID: 27512657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer.
    Freytag SO; Zhang Y; Siddiqui F
    Mol Ther Oncolytics; 2015; 2():15006-. PubMed ID: 26767191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation.
    Fujimori H; Sato A; Kikuhara S; Wang J; Hirai T; Sasaki Y; Murakami Y; Okayasu R; Masutani M
    Sci Rep; 2015 Dec; 5():18231. PubMed ID: 26667181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.
    Al Yaghchi C; Zhang Z; Alusi G; Lemoine NR; Wang Y
    Immunotherapy; 2015; 7(12):1249-58. PubMed ID: 26595180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric oncolytic adenovirus for cancer gene therapy.
    Choi JW; Lee YS; Yun CO; Kim SW
    J Control Release; 2015 Dec; 219():181-191. PubMed ID: 26453806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic viruses: a new class of immunotherapy drugs.
    Kaufman HL; Kohlhapp FJ; Zloza A
    Nat Rev Drug Discov; 2015 Sep; 14(9):642-62. PubMed ID: 26323545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of animal models in cancer vaccine development.
    Wei WZ; Jones RF; Juhasz C; Gibson H; Veenstra J
    Vaccine; 2015 Dec; 33(51):7401-7407. PubMed ID: 26241945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.